All these multifaceted beneficial effects of clove EO prompted us to evaluate this natural product as potential treatment option of campylobacteriosis in a preclinical setting for the first time by using C. jejuni infected microbiota-depleted IL-10−/− mice. The gene discussed is IL10; the disease is campylobacteriosis.